20908 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
METHOD SYSTEM AND APPARATUS FOR DRUG DELIVERY AND TREATMENT
#2BICYCLIC FERROPORTIN INHIBITORS
#3PDK4 as a Cell-Aging Intervention Target and Its Use in Chemotherapy and Anticancer
#4MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#5CARTILAGE REGENERATION COMPOSITION
#6NOVEL COMBINATIONS OF ANTIBIOTICS AND NON-ANTIBIOTIC DRUGS EFFECTIVE IN VIVO AGAINST GRAM-POSITIVE BACTERIA, IN PARTICULAR METHICILLIN-RESISTANT S. AUREUS (MRSA)
#7Methods for Treating a Health Condition with Probiotics
#8COMPOSITION FOR ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY CONTAINING HALOGENATED PHENOL DERIVATIVE AS ACTIVE INGREDIENT
#9Method and Device for Whole Organ Pulsed Electric Field Application for Irreversible Electroporation
#10CXCR4 ANTAGONIST LOADED LIPOSOMES AND SILICASOMES
#11Methods and Kits to Prevent And/Or Treat Cardiac Disorders
#12LIPOSOMAL FORMULATION AND USE IN A COMBINATION PRODUCT AS AN ANTI-TUMOUR THERAPY
#13COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING
#14VACCINE ADJUVANTS AND FORMULATIONS
#15TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
#16METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#17METHOD OF USING AQUEOUS SOLUTION OF PROPYLENE GLYCOL TO INHIBIT DEGRADATION OF DALBAVANCIN HYDROCHLORIDE, DALBAVANCIN INJECTION FORMULATION, PREPARATION METHOD AND METHOD OF USING THE SAME
#18ACTIVE AGENT-ELUTING HEMOSTATIC AGENTS AND METHODS OF USE THEREOF
#19REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS
#20METHODS OF LOCAL IRRIGATION FOR TREATING INFECTIONS
#21IRRIGATION SYSTEM AND METHODS OF USE
#22NOVEL COMPOSITION
#23PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#24METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH FECAL MICROBIOTA TRANSPLANT
#25METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS
#26STING AGONIST-CONTAINING UREASE-POWERED NANOMOTOR-BASED BLADDER CANCER IMMUNOTHERAPY AGENT
#27NANOPARTICLE DOPED POLYETHYLENE GLYCOL BASED GELS AND MEDICAL DEVICES FOR DRUG DELIVERY
#28COMPOSITIONS COMPRISING VANCOMYCIN
#29NOVEL THERAPEUTIC METHODS OF USING PEPTIDOGLYCAN MUROPEPTIDES TO PROMOTE ATP SYNTHASE ACTIVITY AND MITOCHONDRIAL HOMEOSTASIS AND DEVELOPMENT
#30Use of Salvianolic Acid E in the Preparation of Drugs Targeting Senescent Cells, Inhibiting Tumors or Extending Lifespan
#31GLYCOPEPTIDE COMPOSITIONS
#32ALPHA DEFENSIN ASSAY FOR DIAGNOSING NOSOCOMIAL VENTRICULITIS
#33TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE
#34ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#35Electro Magnetic Transducer Network in the Enhancement of Anti-infective Strategies
#36ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#37METHODS OF LOCAL IRRIGATION FOR TREATING FUNGAL INFECTIONS
#38COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION
#39INACTIVATING BACTERIA WITH ELECTRIC PULSES AND ANTIBIOTICS
#40HEATING APPARATUS AND METHODS
#41ALPHA 2 ADRENERGIC RECEPTOR BLOCKADE FOR THE TREATMENT OF C. DIFFICILE COLITIS
#42CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF
#43METHOD FOR THE TREATMENT OF VASCULAR ANOMALIES BY ADMINISTERING ONE OR MORE SCLEROSING AGENTS AND APPLYING A SERIES OF ELECTRIC PULSES
#44NOVEL COMBINATION TREATMENT REGIMEN OF BACTERIAL INFECTIONS
#45PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES
#46MODIFIED PEPTIDOMIMETICS AND METHODS OF USE
#47ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION
#48GEPOTIDACIN AND VANCOMYCIN FOR USE IN THE TREATMENT OF AN INFECTION CAUSED BY STAPHYLOCOCCUS SAPROPHYTICUS
#49MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#50A COMPOSITION FOR TREATING OCULAR INFECTIONS AND A METHOD OF PREPARATION THEREOF
#51METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#52P53 PEPTIDOMIMETIC MACROCYCLES
#53MEDICAL DEVICE FOR PREVENTING SURGICAL INFECTION
#54USE OF A MURAMYL PEPTIDE IN THE TREATMENT OF SKELETAL GROWTH RETARDATION
#55COMPOSITIONS AND METHODS OF CLOSTRIDIODIDES DIFFICILE TREATMENT, DECOLONIZATION, AND PREVENTION
#56IRRIGATION SYSTEM AND METHODS OF USE
#57CARRIER OR AUXILIARY MATERIAL OF OPHTHALMIC PREPARATION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#58FORMULATIONS OF VANCOMYCIN
#59Treatment of Breast and Other Cancers Using Zinc Chloride Instead of Radiation
#60COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM
#61CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS
#62Non-Toxin Antigens For Clostridioides Difficile Vaccine
#63ADVANCED METHOD AND KIT FOR WOUND TREATMENT
#64COMPOSITION OF VANCOMYCIN AQUEOUS SOLUTION
#65INTESTINAL MICROBIOTA AND GVHD
#66THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#67LIQUID DALBAVANCIN COMPOSITIONS
#68FOAM COMPOSITIONS FOR TREATING CLOSTRIDIOIDES DIFFICILE INFECTIONS
#69METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR
#70URINARY TRACT CANCER TREATMENT GUIDED BY MUTATIONAL LANDSCAPE
#71METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#72Translational Activators, Including Methods of Discovery and Uses Thereof
#73Microbiome protection from oral antibiotics
#74TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#75PEPTIDE AMPHIPHILE COMPOSITIONS AND METHODS OF USE THEREOF
#76METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS
#77RIFAMYCIN ANALOGS IN COMBINATION WITH VANCOMYCIN AND USES THEREOF
#78Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#79METHODS OF COLONIZING A MICROBIOME, TREATING AND/OR PREVENTING INFLAMMATORY BOWEL DISEASE AND GRAFT VERSUS HOST DISEASE
#80COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND RELATED DISORDERS
#81FLUIDIC DEVICE FOR THE DETECTION, CAPTURE, OR REMOVAL OF A DISEASE MATERIAL
#82Liquid dalbavancin compositions
#83USE OF GOJI GLYCOPEPTIDE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#84TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#85TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
#86Use of an intervertebral disc fibrosis-inducing substance in preparation of medication
#87ORAL LIPOSOMAL COMPOSITIONS
#88Implantable cellular and biotherapeutic agent delivery canister
#89COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF
#90ANTIMICROBIAL DRESSING FOR WOUNDS
#91Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the Same
#92REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS
#93DRUG CONJUGATES AND USES THEREOF
#94Inactivating bacteria with electric pulses and antibiotics
#95DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
#96METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#97Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents
#98VACCINE ADJUVANTS AND FORMULATIONS
#99A BROADLY NEUTRALIZING MOLECULE AGAINST CLOSTRIDIUM DIFFICILE TOXIN B
#100MESOPOROUS NANOPARTICLES SYSTEM TO INCREASE THE BIOFILM ERADICATION ACTIVITY BY MEANS OF THE CARRYING AND THE ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT AND RELATED PRODUCTION METHOD
#101PHARMACEUTICAL COMPOSITION FOR TREATING CDI COMPRISING CLAY MINERAL COMPLEX, AND METHOD FOR PRODUCING SAME
#102METHODS FOR THE PREVENTION OR TREATMENT OF ANTHRAX INFECTION
#103Composition and method for new antimicrobial agents with secondary mode of action provided by conjugation of an antimicrobial to a guanidinium-rich molecular transporter
#104CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES
#105AQUEOUS SOLUTION
#106REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS
#107ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#108Methods for Treating a Health Condition with Probiotics
#109ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS
#110Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#111COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#112LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE
#113METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE
#114Formulations of vancomycin
#115METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION
#116METHODS AND COMPOSITIONS FOR TREATING DIABETIC FOOT ULCERS
#117MEDICINE LOADED NANO-CAPSULE ADDITIVE PMMA CEMENT
#118USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION
#119METHODS FOR THE TREATMENT OF MYELOID DERIVED SUPPRESSOR CELLS RELATED DISORDERS
#120METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#121MEDICATION THAT PROTECTS THE INTESTINAL MICROBIOTA AND THEIR PREPARATION METHODS AND APPLICATIONS
#122LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT
#123ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC PRODUCTS
#124COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID
#125MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#126COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING
#127MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA
#128Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#129Microbiome protection from oral antibiotics
#130CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE
#131PLATELETS LOADED WITH ANTI-CANCER AGENTS
#132Hydrophilic Degradable Microspheres for Local Delivering of Glycopeptide Antibiotics and Polycationic Peptide Antibiotics
#133RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
#134Compositions and methods for delivering an agent to a wound
#135ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY
#136Methods for continuous manufacture of liposomal drug products
#137ANTIBACTERIAL PRODUCTS
#138Glycopeptide compositions
#139BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#140Antibiotic formulations for lower back pain
#141NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS
#142COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER USING DEUBIQUITINASE INHIBITORS
#143METHOD AND COMBINATION FOR THE SUPPRESSION OF COVID-19 VIRUS
#144NON-STICK ANTIBIOTIC GELS
#145COMPOSITIONS AND METHODS FOR BIOORTHOGONAL SURFACE COATING
#146Composition and method for vancomycin oral liquid
#147IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS
#148METHODS AND MATERIALS FOR TREATING CANCER
#149ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF
#150Implantable cellular and biotherapeutic agent delivery canister
#151GLYCOPEPTIDE ANTIBIOTIC COMBINATION THERAPY
#152HER2 MUTATION INHIBITORS
#153METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDS
#154Inhalable antimicrobial particles and methods of making the same
#155USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES
#156COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#157Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin
#158UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#159Pharmaceutical ophthalmic compositions
#160TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS
#161Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention
#162Pharmaceutical compositions and related methods of delivery
#163Pharmaceutical compositions and related methods of delivery
#164TREATING ACUTE LIVER DISEASE WITH TLR-MIK INIHIBITORS
#165Glycopeptide compositions
#166METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS
#167Methods of generating, repairing and/or maintaining connective tissue in vivo
#168THERAPEUTIC MITOCHONDRIAL PEPTIDES
#169SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#170HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#171METHODS AND COMPOSITIONS FOR THE TREATMENT OF HPV-RELATED CANCER
#172Vancomycin Liposome Compositions and Methods
#173MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF
#174NOVEL ENTERIC COMBINATION THERAPY
#175RATIONALLY DESIGNED LAWSONE DERIVATIVES AS ANTIMICROBIALS AGAINST MULTIDRUG-RESISTANT STAPHYLOCOCCUS AUREUS
#176MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF
#177Compositions and methods for treating and preventing infections
#178COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER
#179TOPICAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME
#180PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONS
#181PHARMACEUTICAL COMPOSITION AND KIT CONTAINING NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM beta-LACTAMASE INHIBITORY COMPOUND AND ANTIBACTERIAL COMPOUND OR SALTS THEREOF
#182ORAL ADMINISTRATION OF UNSTABLE OR POORLY-ABSORBED DRUGS
#183Enteric combination therapy
#184COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES
#185RANDOM COPOLYMER STABILIZED NANOPARTICLES ENCAPSULATING SOLUBLE HYDROPHILIC COMPOUNDS
#186METHODS AND COMPOSITIONS FOR TREATING CANCER
#187COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY
#188QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA
#189STABLE PHARMACEUTICAL FORMULATIONS OF PEPTIDE AND PROTEIN DRUGS
#190USE OF CANNABIDIOL IN COMBINATION WITH ANTIBIOTICS
#191NUCLEIC ACID PROBES
#192COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM
#193METHOD OF TREATING INFECTIVE ENDOCARDITIS
#194CANNABINOID COMPOSITIONS AND USE THEREOF
#195ANTI-MICROBIAL METHODS AND MATERIALS
#196Materials and Methods for Enhanced Treatment and Prevention of Biofilms
#197Implantable cellular and biotherapeutic agent delivery canister
#198MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#199Fluidic device for the detection, capture, or removal of a disease material
#200Glycopeptide antibiotics liquid formulations and methods and uses thereof
#201GLYCOPEPTIDE ANTIBIOTICS LIQUID FORMULATIONS AND METHODS AND USES THEREOF
#202Lipo-glycopeptide cleavable derivatives and uses thereof
#203METHODS FOR IMPROVING THE EFFICACY OF A SURVIVIN THERAPEUTIC IN THE TREATMENT OF TUMORS
#204COMPOSITIONS PROVIDING ENHANCED ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA AND USE THEREOF
#205Pharmaceutical compounds and therapeutic methods
#206USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
#207METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#208Heating apparatus and methods
#209Inactivating bacteria with electric pulses and antibiotics
#210Method of local antibiotic treatment of infective endocarditis
#211COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#212Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#213INHIBITING INFLAMMATION
#214BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF
#215PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS
#216BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#217CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME
#218Compositions and methods for treating epilepsy and related disorders
#219TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL
#220MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#221RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
#222PHARMACEUTICAL COMPOSITION COMPRISING TEICOPLANIN
#223NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
#224Vaccine adjuvants and formulations
#225NANOPARTICLE FORMULATIONS AND METHODS OF USE FOR ALPHA CONNEXIN C-TERMINAL PEPTIDES
#226MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR
#227Processes for preparing functionalized cyclooctenes
#228ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS
#229COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING
#230BIOACTIVE VITAMIN COMBINATIONS
#231Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#232ANTIBACTERIAL COMBINATIONS
#233Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#234COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR
#235Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof
#236METHOD AND DEVICE FOR TREATING MICROSCOPIC RESIDUAL TUMORS REMAINING IN TISSUES FOLLOWING SURGICAL RESECTION
#237Methods of preventing and treating COVID-19 infection with probiotics
#238Methods to Expand the Spectrum of Gram-Positive Antibiotics
#239Fine nano-sized medicinal agent and use thereof
#240Drug-Eluting Spacer for Joints of the Human Body
#241Methods of treating hepatic encephalopathy
#242Bactericidal debridement compositions for surgical site infections and chronic wound healing
#243MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT
#2445-ACETAMIDOMETHYL-OXAZOLIDINONE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
#245NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF
#246METHODS AND COMPOSITIONS FOR DELIVERY OF A THERAPEUTIC AGENT
#247Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#248PH-responsive polymer-drug conjugates for enhanced antibacterial efficacy
#249Formulations of vancomycin
#250COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#251PATHOGEN CONTROL COMPOSITIONS AND USES THEREOF
#252Hydrogel compositions
#253Conjugates comprising a temperature-responsive polymer and a ligand capable of binding ergosterol
#254Pharmaceutical composition for prevention or treatment of flavivirus infection
#255MESOPOROUS ELASTOMER
#256Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#257Microbiome protection from oral antibiotics
#258Glycopeptide compositions
#259THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#260Treatment for reducing adverse events including chemotherapy discomfort and other conditions
#261MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#262Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
#263Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#264Enteric combination therapy
#265COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID
#266COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS
#267DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
#268Treating or preventing adverse liver conditions
#269BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#270ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#271Compositions and methods for delivering an agent to a wound
#272Antimicrobial articles produced by additive manufacturing
#273TREATMENT AND PREVENTION OF PLANTAR WARTS
#274TREATMENT AND PREVENTION OF GENITAL WARTS
#275Diiodohydroxyquinoline for the treatment of clostridium difficile infection
#276Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof
#277COMPOSITION COMPRISING A POLYMYXIN AND TEICOPLANIN
#278TCO conjugates and methods for delivery of therapeutic agents
#279Methods and compositions for treating diabetic foot ulcers
#280Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
#281Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
#282COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID
#283Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor
#284Nasal drug delivery device and method of making same
#285METHOD AND SYSTEM FOR PRODUCING HIGH PURITY VANCOMYCIN HYDROCHLORIDE
#286COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID
#287METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME
#288Supramolecular glycosaminoglycans
#289TISSUE RESIDENT MEMORY CELL PROFILES, AND USES THEREOF
#290Methods for continuous manufacture of liposomal drug products
#291BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#292Pharmaceutical compositions and related methods of delivery
#293METHODS FOR TREATING CANCER AND PROTECTING RENEWABLE TISSUES
#294Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#295Macrocyclic broad spectrum antibiotics
#296PROBIOTIC RECOLONISATION THERAPY
#297Inactivating bacteria with electric pulses and antibiotics
#298DRUG DELIVERY SYSTEMS FOR TREATMENT OF INFECTIONS
#299GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF
#300METHODS OF TREATING HEPATIC ENCEPHALOPATHY